We agree that the FDA should require analysis of data for sex differences in effectiveness and safety for all medicines during development. Research on marketed drugs should be required when there is scientific evidence of a possible difference.
View this week's episode of 60 Minutes, "Sex matters: Drugs can affect sexes differently" below: